Fingerprint
Dive into the research topics of 'Long-term safety of vedolizumab for inflammatory bowel disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Long-term safety of vedolizumab for inflammatory bowel disease
Edward V. Loftus, Brian G. Feagan, Remo Panaccione, Jean Frédéric Colombel, William J. Sandborn, Bruce E. Sands, Silvio Danese, Geert D’Haens, David T. Rubin, Ira Shafran, Andrejus Parfionovas, Raquel Rogers, Richard A. Lirio, Séverine Vermeire
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations